Neurology / Alzheimer's Disease
Indication
Alzheimer's Disease
Assets addressing this indication.
Total attributable cost
$409.0B
$55,270/patient
Drug spend
$27.0B
$3,650/patient
7% of total cost is drugs
All stages (2026 estimate) · US
Neurology / Alzheimer's Disease
Indication
Assets addressing this indication.
Total attributable cost
$409.0B
$55,270/patient
Drug spend
$27.0B
$3,650/patient
7% of total cost is drugs
All stages (2026 estimate) · US
119 of 119 assets